-
EP1459748
European procedure
Extract from the Register of European Patents
EP About this file: EP1459748
| EP1459748 - (S,S)-reboxetine for treating peripheral neuropathy [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 17.02.2006 Database last updated on 31.08.2024 | Most recent event Tooltip | 16.04.2010 | Change - lapse in a contracting state | published on 19.05.2010 [2010/20] | Applicant(s) | For all designated states Pharmacia & Upjohn Company LLC 301 Henrietta Street Kalamazoo, MI 49001 / US | [2005/22] |
| Former [2004/39] | For all designated states Pharmacia & Upjohn Company 301 Henrietta Street Kalamazoo, MI 49007 / US | Inventor(s) | 01 /
Ahmed, Saeeduddin 9889 Defoe Court Portage Michigan 49002 / US | 02 /
Birgerson, Lars 54 Hillcrest Road Martinsville New Jersey 08836 / US | 03 /
Cetera, Pasquale 5 Pine Place Annandale New Jersey 08801 / US | 04 /
Marshall, Robert Clyde 7560 Fieldwood Circle Mattawan Michigan 49071 / US | 05 /
McArthur, Robert 531 Carrington Court Kalamazoo Michigan 49009 / US | 06 /
Taylor, Duncan P. 8722 West F. Avenue Kalamazoo Michigan 49009 / US | 07 /
Wong, Erik H.F. 7352 Hampstead Lane Portage Michigan 49024 / US | [2004/39] | Representative(s) | Duncan, Garreth Andrew Pfizer Limited UK Patent Department Ramsgate Road Sandwich Kent CT13 9NJ / GB | [N/P] |
| Former [2004/39] | Duncan, Garreth Andrew Pfizer Limited, UK Patent Department, Ramsgate Road Sandwich, Kent CT13 9NJ / GB | Application number, filing date | 04013379.5 | 22.06.2000 | [2004/39] | Priority number, date | US19990141968P | 01.07.1999 Original published format: US 141968 P | US19990144131P | 16.07.1999 Original published format: US 144131 P | US19990158256P | 06.10.1999 Original published format: US 158256 P | US19990170381P | 13.12.1999 Original published format: US 170381 P | [2004/39] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP1459748 | Date: | 22.09.2004 | Language: | EN | [2004/39] | Type: | B1 Patent specification | No.: | EP1459748 | Date: | 13.04.2005 | Language: | EN | [2005/15] | Type: | B8 Corrected title page of specification | No.: | EP1459748 | Date: | 08.06.2005 | [2005/23] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 04.08.2004 | Classification | IPC: | A61K31/5375, A61P25/02 | [2004/39] | CPC: |
A61K31/5375 (EP);
A61P13/00 (EP);
A61P21/00 (EP);
A61P25/00 (EP);
A61P25/02 (EP);
A61P25/06 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P29/00 (EP);
A61P43/00 (EP)
(-)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2004/39] | Extension states | AL | 07.06.2004 | LT | 07.06.2004 | LV | 07.06.2004 | MK | 07.06.2004 | RO | 07.06.2004 | SI | 07.06.2004 | Title | German: | (S,S)-Reboxetin zur Behandlung von peripheren Neuropathien | [2004/39] | English: | (S,S)-reboxetine for treating peripheral neuropathy | [2004/39] | French: | (S,S)-réboxétine pour traiter les neuropathies périphériques | [2004/39] | Examination procedure | 07.06.2004 | Examination requested [2004/39] | 28.09.2004 | Amendment by applicant (claims and/or description) | 17.12.2004 | Communication of intention to grant the patent | 25.01.2005 | Fee for grant paid | 25.01.2005 | Fee for publishing/printing paid | Parent application(s) Tooltip | EP00941659.5 / EP1196172 | Opposition(s) | 16.01.2006 | No opposition filed within time limit [2006/14] | Fees paid | Renewal fee | 07.06.2004 | Renewal fee patent year 03 | 07.06.2004 | Renewal fee patent year 04 | 07.06.2004 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | |||
| Former [2007/34] | IT | 22.06.2005 | Documents cited: | Search | [DA]GB2167407 (ERBA FARMITALIA) [DA] 1-7 * abstract * * page 4, line 50 - page 5, line 25; examples 11-13; claim - *; | [E]WO0147503 (PHARMACIA AB [SE], et al) [E] 1-7 * abstract * * page 3, line 5 - line 32 * * page 4, line 23 - page 5, line 2; examples 17,18; claims 1,4,7,20,23 *; | [E]WO0162236 (UPJOHN CO [US], et al) [E] 1-7 * abstract * * page 6, line 28 - page 7, line 7; example -; claims 1,3,7,8 *; | [A] - FRIGERIO E ET AL, "PHARMACOKINETICS OF REBOXETINE ENANTIOMERS IN THE DOG", CHIRALITY, WILEY-LISS, NEW YORK, US, (1997), vol. 9, ISSN 0899-0042, pages 303 - 306, XP000991008 [A] 1-7 * the whole document * DOI: http://dx.doi.org/10.1002/(SICI)1520-636X(1997)9:3<303::AID-CHIR17>3.0.CO;2-R | [A] - DOSTERT P ET AL, "REVIEW OF THE PHARMACOKINETICS AND METABOLISM OF REBOXETINE, A SELECTIVE NORADRENALINE REUPTAKE INHIBITOR", EUROPEAN NEUROPSYCHOPHARMACOLOGY, ELSEVIER SCIENCE PUBLISHERS BV, AMSTERDAM, NL, (1997), vol. 7, no. SUPPL 1, ISSN 0924-977X, pages S23 - S35, XP000989913 [A] 1-7 * the whole document * DOI: http://dx.doi.org/10.1016/S0924-977X(97)00417-3 | [A] - BURROWS G D ET AL, "ANTIDEPRESSANT EFFICACY AND TOLERABILITY OF THE SELECTIVE NOREPINEPHRINE REUPTAKE INHIBITOR REBOXETINE: A REVIEW", JOURNAL OF CLINICAL PSYCHIATRY, XX, XX, (1998), vol. 59, no. SUPPL 14, ISSN 0160-6689, pages 4 - 7, XP000989995 [A] 1-7 * the whole document * | [A] - ANONYMOUS, "REBOXETINE - ANOTHER NEW ANTIDEPRESSANT", DRUG AND THERAPEUTICS BULLETIN, CONSUMERS ASSOCIATION, LONDON, GB, (199811), vol. 36, no. 11, ISSN 0012-6543, pages 86 - 88, XP001011361 [A] * the whole document * |